Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer.
about
Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection.Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study.Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis.Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatmentAssociation of circulating sTRAIL and high-sensitivity CRP with type 2 diabetic nephropathy and foot ulcers.Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers.Role of apoptosis in colon cancer biology, therapy, and preventionAn overview of the effects of anti-IgE therapies.Serum soluble tumour necrosis factor related apoptosis-inducing ligand level and peripheral eosinophil count in patients with nasal polyposis.TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy.Perifosine enhances bevacizumab-induced apoptosis and therapeutic efficacy by targeting PI3K/AKT pathway in a glioblastoma heterotopic model.
P2860
Q33910907-71D2659B-531F-4ADA-9CDB-C77FC173B1FDQ34359953-962675D7-4531-4B2D-8291-5C4144DBB247Q35198371-4323D27E-238A-4B63-B254-029C8DA621CBQ36277943-52BEF01B-5E8A-4608-8C8E-21F75F4DDB31Q36576759-9FEC0E19-B03B-4072-BE31-758B9FA880A7Q36577451-E321F3AF-D585-4ACF-A9B1-86B015D7B28EQ37145768-0B45E871-9683-47A0-A2FD-CE3BA295D138Q37255453-81ECDD01-EC20-448F-9755-71FBF3C87FAAQ37331465-41E410C8-7030-47BC-8540-C15897C31719Q38252958-60F03C5D-BD92-4902-A970-ED92C7556B36Q39042798-1C14A881-BB4A-4979-B565-6E5BD35D7657Q41123139-4E46ACA0-7C5F-4A3C-80D5-F926C0BADC65Q50071959-86CF50C5-B41E-412B-A93A-0BB09CD684E0Q52313276-7708C406-4600-4843-9E4A-311A4CED40DE
P2860
Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Increased serum sTRAIL levels ...... eated metastatic colon cancer.
@ast
Increased serum sTRAIL levels ...... eated metastatic colon cancer.
@en
Increased serum sTRAIL levels ...... eated metastatic colon cancer.
@nl
type
label
Increased serum sTRAIL levels ...... eated metastatic colon cancer.
@ast
Increased serum sTRAIL levels ...... eated metastatic colon cancer.
@en
Increased serum sTRAIL levels ...... eated metastatic colon cancer.
@nl
prefLabel
Increased serum sTRAIL levels ...... eated metastatic colon cancer.
@ast
Increased serum sTRAIL levels ...... eated metastatic colon cancer.
@en
Increased serum sTRAIL levels ...... eated metastatic colon cancer.
@nl
P2093
P2860
P356
P1433
P1476
Increased serum sTRAIL levels ...... eated metastatic colon cancer.
@en
P2093
Atil Bisgin
Aysegul Kargi
Burhan Savas
Cigdem Aydin
Deniz Ekinci
Salih Sanlioglu
P2860
P2888
P356
10.1186/1471-2407-12-58
P407
P577
2012-02-07T00:00:00Z
P5875
P6179
1029871828